Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases
Clinical trial NCT06683703 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06683703
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.